1 We excluded studies based on design, target population, and o
2 We excluded studies based on high-risk or clinical population
3 We excluded studies concerning indwelling vascular catheters,
4 We excluded studies containing mixed cohorts of migrants and
5 We excluded studies done in high-income countries.
6 We excluded studies evaluating cross-linking for nonectatic i
7 We excluded studies focusing on special populations, infants
8 We excluded studies if children were only tested at birth.
9 We excluded studies if continued cannabis use or discontinued
10 We excluded studies if more than 20% of participants were mil
11 We excluded studies if they contained duplicate data from the
12 We excluded studies if they included central venous catheters
13 We excluded studies in high-income countries, those involving
14 We excluded studies in high-income countries, those involving
15 We excluded studies in patients with chronic obstructive pulm
16 We excluded studies in patients with treatment resistance, fi
17 We excluded studies in which malaria in pregnancy was not con
18 We excluded studies in which recruitment was not consecutive,
19 We excluded studies investigating the use of whole blood or h
20 We excluded studies limited to patients with acute myocardial
21 We excluded studies of deliberate overdose and depression in
22 We excluded studies of only patients with a prodrome or solel
23 We excluded studies of patients with extrapulmonary tuberculo
24 We excluded studies of supplements, children, or individuals
25 We excluded studies of vaccinations in investigation or devel
26 We excluded studies performed in non-developed countries, and
27 We excluded studies restricted to hospitalised patients or sp
28 We excluded studies that combined LRH and RRH without supplyi
29 We excluded studies that did not (1) dichotomize neurologic o
30 We excluded studies that did not allow comparison between mor
31 For the mortality and diagnostic value searches,
we excluded studies that did not include an effect estimate o
32 We excluded studies that did not include supervised schizonti
33 We excluded studies that did not use both minor and major det
34 We excluded studies that focused exclusively on treatment-res
35 We excluded studies that had been conducted only in children
36 We excluded studies that included pediatric or hospitalized p
37 We excluded studies that only measured faecal indicator bacte
38 We excluded studies that reported only the current prevalence
39 We excluded studies that scored less than 3 points.
40 We excluded studies that used selected samples or were only q
41 We excluded studies that were not in humans, or reported only
42 We excluded studies that were not published in English.
43 We excluded studies using non-human samples and antimicrobial
44 We excluded studies whose population of interest was neonatal
45 We excluded studies with <50 patients with a single disease e
46 We excluded studies with an active control agent (which might
47 We excluded studies with an unclear or closed population samp
48 We excluded studies with fewer than 15 patients.
49 We excluded studies with fewer than 50 patients.
50 We excluded studies with pharmacological or device-based inte